Tissue Distribution and Antifungal Effect of Liposomal Itraconazole in Experimental Cryptococcosis and
暂无分享,去创建一个
[1] Claude Carbón,et al. Reduction of free amphotericin B acute toxicity in mice after intravenous administration of empty liposomes. , 1990, The Journal of infectious diseases.
[2] R. Hector,et al. Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis , 1990, Antimicrobial Agents and Chemotherapy.
[3] J. Bartlett,et al. Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. , 1991, Reviews of infectious diseases.
[4] Claude Carbón,et al. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits. , 1989, The Journal of pharmacology and experimental therapeutics.
[5] Aquilur Rahman,et al. Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice , 1989, Antimicrobial Agents and Chemotherapy.
[6] T. Walsh,et al. Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice , 1989, Infection and immunity.
[7] J. Sculier,et al. Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections. , 1988, European journal of cancer & clinical oncology.
[8] L. Frankel,et al. Treatment of hepatosplenic candidiasis with liposomal-amphotericin B. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] J. Levron,et al. The pharmacokinetics of itraconazole in animals and man: an overview , 1987 .
[10] P. Bierling,et al. Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients , 1986, Cancer.
[11] J. Perfect,et al. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits , 1986, Antimicrobial Agents and Chemotherapy.
[12] A. Zuger,et al. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. , 1986, Annals of internal medicine.
[13] J. Reuben,et al. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. , 1985, The Journal of infectious diseases.
[14] J. Graybill,et al. R 51211 (itraconazole) therapy of murine cryptococcosis. , 1984, Sabouraudia.
[15] F. Szoka,et al. Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice , 1984, Antimicrobial Agents and Chemotherapy.
[16] B. Strom,et al. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. , 1984, Annals of internal medicine.
[17] G. Lopez-Berestein,et al. Altered tissue distribution of amphotericin B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans. , 1984, Cancer drug delivery.
[18] E. Hersh,et al. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. , 1983, The Journal of infectious diseases.
[19] J. Kersey,et al. A Prospective Study of Infectious Diseases Following Bone Marrow Transplantation: Emergence of Aspergillus and Cytomegalovirus as the Major Causes of Mortality , 1983, Infection Control.
[20] E. Wisse,et al. UPTAKE OF LIPOSOMES BY RAT AND MOUSE HEPATOCYTES AND KUPFFER CELLS , 1983 .
[21] W. Lee,et al. Fungal infections in patients with acute leukemia. , 1982, The American journal of medicine.
[22] J. Graybill,et al. Amphotericin B in liposomes: a novel therapy for histoplasmosis. , 1982, The American review of respiratory disease.
[23] L. Young. Nosocomial infections in the immunocompromised adult. , 1981, The American journal of medicine.